This New Drug Could Solve the GLP-1 Plateau Problem
Roche’s experimental enicepatide reduced weight without a plateau through week 48 while also improving blood sugar in adults with diabetes and obesity.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.